NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
This publication is provided for historical reference only and the information may be out of date.
This TIP focuses on infectious diseases that are prevalent in and especially harmful to patients in drug treatment, and that can be medically managed by treatment staff or through referrals for primary care. The treatment recommendations in this TIP are largely, but not exclusively, based on guidelines from the Centers for Disease Control and Prevention (CDC). Trained medical staff are needed to diagnose and treat these diseases. Treatment providers who do not offer such medical resources are encouraged to refer their patients to community-based health care professionals. Followup care of those patients referred initially to other health care professionals should be provided.
Contents
- What Is a TIP?
- Consensus Panel Members
- Foreword
- Definition of the Term "Drug Use"
- Chapter 1 - Introduction
- Infectious Diseases Linked With Drug Use
- Other Infectious Diseases Common in Treatment Populations
- Special Problems of Sexually Transmitted Diseases in Younger People and Women
- Infectious Disease Screening and Drug Treatment
- Guidelines for Infectious Disease Screening
- The Consensus Development Process
- Recommendations of the Consensus Panel
- Using These Guidelines
- Sources
- Chapter 2 - Issues for Counselors
- Chapter 3 - Legal and Ethical Issues
- Chapter 4 - Issues for Treatment Program Administrators: Staff and Community Development and Environmental Safety
- Chapter 5 - The Initial Patient Contact
- Chapter 6 - Summary Statement on Tuberculosis
- Chapter 7 - Tuberculosis
- Chapter 8 - Multidrug-Resistant Tuberculosis
- Chapter 9 - Human Immunodeficiency Virus and the Acquired Immunodeficiency Syndrome
- Chapter 10 - Syphilis
- Chapter 11 - Introduction to Viral Hepatitis
- Chapter 12 - Viral Hepatitis B
- Chapter 13 - Viral Hepatitis C
- Chapter 14 - Viral Hepatitis A
- Chapter 15 - Viral Hepatitis D
- Chapter 16 - Gonorrhea
- Chapter 17 - Chlamydia
- Chapter 18 - Herpes Simplex
- Chapter 19 - Chancroid
- Appendix A - Bibliography
- Appendix B - Federal Resource Panel on Screening for Infectious Diseases Among Substance Abusers
- Appendix C - TIP Field Reviewers
- Appendix D - Resource List
- Appendix E - Program Models and Sample Budgets
- Appendix F - Quality Assurance
- Appendix G - HIV/AIDS Prevention Bulletin
The opinions expressed herein are those of the Consensus Panel members and do not reflect the official position of SAMHSA or any other part of the U.S. Department of Health and Human Services (DHHS). No official support or endorsement of SAMHSA or DHHS is intended or should be inferred. The guidelines proffered in this document should not be considered as substitutes for individualized patient care and treatment decisions.
The U.S. Government does not endorse or favor any specific commercial product or company. Trade, proprietary, or company names appearing in this publication are used only because they are considered essential in the context of this Treatment Improvement Protocol.
Care has been taken to make the information in this Treatment Improvement Protocol current. However, the user of this document should realize that regimens for treating infectious diseases do change, especially in the treatment of HIV/AIDS and multidrug-resistant tuberculosis. If there is any question about the appropriateness of nay information contained in this protocol, or question about whether the information is current with the latest advances in treatment, the reader is encouraged to consult a specialist in infectious diseases.
- Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.[MMWR Recomm Rep. 2012]Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.Centers for Disease Control and Prevention (CDC). MMWR Recomm Rep. 2012 Nov 9; 61(RR-5):1-40.
- Dental screening and referral of young children by pediatric primary care providers.[Pediatrics. 2004]Dental screening and referral of young children by pediatric primary care providers.dela Cruz GG, Rozier RG, Slade G. Pediatrics. 2004 Nov; 114(5):e642-52.
- Improving integration and coordination of funding, technical assistance, and reporting/data collection: recommendations from CDC and USAPI stakeholders.[Pac Health Dialog. 2011]Improving integration and coordination of funding, technical assistance, and reporting/data collection: recommendations from CDC and USAPI stakeholders.Ka'opua LS, White SF, Rochester PF, Holden DJ. Pac Health Dialog. 2011 Mar; 17(1):185-97.
- Review Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management.[Clin Toxicol (Phila). 2008]Review Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management.Manoguerra AS, Erdman AR, Woolf AD, Chyka PA, Caravati EM, Scharman EJ, Booze LL, Christianson G, Nelson LS, Cobaugh DJ, et al. Clin Toxicol (Phila). 2008 Aug; 46(7):661-76.
- Review Epidemiology.[Medical Microbiology. 1996]Review Epidemiology.Brachman PS. Medical Microbiology. 1996
- Screening for Infectious Diseases Among Substance AbusersScreening for Infectious Diseases Among Substance Abusers
Your browsing activity is empty.
Activity recording is turned off.
See more...